Pulsed Field Ablation Market: Distribution by Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Respiratory Disorders and Dermatological Disorders), Product Components (Catheters and Generators), Application Areas (Ablation, and Ablation and Mapping), Source of Ablation (Pulsed Field Energy, Pulsed Field and Radiofrequency Energy, and Pulsed Field and Cryoablation Energy), Key Geographical Regions (North America, Europe and Asia-Pacific): Market Share of Key Companies, Industry Trends and Global Forecasts, 2023-2035
The pulsed field ablation market is expected to reach USD 5.5 billion by 2035 anticipated to grow at a CAGR of 40% during the forecast period 2023-2035.
In recent years, there's been a focused effort among medical practitioners to explore less invasive procedures for better patient outcomes, especially in conditions like atrial fibrillation. While traditional surgeries work, they bring issues like scarring, longer recovery, and higher risks. Ablation therapies, which use energy sources to eliminate abnormal tissues without surgery, have become popular. Yet, the usual methods using heat energy can harm healthy tissue and cause discomfort post-procedure. Pulsed field ablation (PFA) has emerged as a safer option. PFA uses high-voltage electrical pulses in short bursts to precisely target abnormal tissues without harming healthy cells. Unlike thermal ablation, PFA reduces risks and discomfort during recovery by avoiding tissue overheating. This technique, used in various medical areas, shows promise in treating cardiac rhythm disorders like atrial fibrillation and ventricular tachycardia. In cardiac ablation with PFA, controlled electrical energy creates small scars in cardiac tissue, restoring a regular heartbeat by blocking irregular electrical signals.
Atrial fibrillation's prevalence has significantly increased over 50 years, as per the Framingham Heart Study. The rising disease burden and ongoing research aiming to expand PFA's uses beyond cardiac ablation are expected to drive substantial market growth in the projected period.
Report Coverage
In recent years, there's been a focused effort among medical practitioners to explore less invasive procedures for better patient outcomes, especially in conditions like atrial fibrillation. While traditional surgeries work, they bring issues like scarring, longer recovery, and higher risks. Ablation therapies, which use energy sources to eliminate abnormal tissues without surgery, have become popular. Yet, the usual methods using heat energy can harm healthy tissue and cause discomfort post-procedure. Pulsed field ablation (PFA) has emerged as a safer option. PFA uses high-voltage electrical pulses in short bursts to precisely target abnormal tissues without harming healthy cells. Unlike thermal ablation, PFA reduces risks and discomfort during recovery by avoiding tissue overheating. This technique, used in various medical areas, shows promise in treating cardiac rhythm disorders like atrial fibrillation and ventricular tachycardia. In cardiac ablation with PFA, controlled electrical energy creates small scars in cardiac tissue, restoring a regular heartbeat by blocking irregular electrical signals.
Atrial fibrillation's prevalence has significantly increased over 50 years, as per the Framingham Heart Study. The rising disease burden and ongoing research aiming to expand PFA's uses beyond cardiac ablation are expected to drive substantial market growth in the projected period.
Report Coverage
- The report investigates pulsed field ablation within therapeutic area, product components, application areas, source of ablation, and key geographical regions
- It analyzes market growth factors such as drivers, restraints, opportunities, and challenges.
- The report evaluates potential market advantages and obstacles, providing insights into the competitive landscape for leading market players.
- Forecasts are made regarding revenue in market segments across three major regions.
- An in-depth outline details the rigorous research methodology employed, including methodologies, assumptions, and quality control measures to ensure accuracy and reliability.
- Economic influences impacting the pulsed field ablation market, encompassing historical trends, currency fluctuations, foreign exchange impacts, recessionary effects, and inflation measurements, are summarized.
- A concise summary captures key insights obtained during research, offering a high-level perspective on the current state and future evolution of the pulsed field ablation market.
- A comprehensive introduction to pulsed field ablation covers various ablation techniques, system components, historical evolution, mechanism of action, therapeutic applications, and advantages.
- Analysis of the current market scenario for pulsed field ablation devices includes product components, catheter specifications, development status, application areas, and target therapeutic domains. Additionally, it provides an overview of companies involved in device development based on specific criteria.
- Assessment of the competitive landscape considers company strength, product competitiveness based on various criteria, and development status of pulsed field ablation devices.
- Detailed profiles of leading pulsed field ablation companies encompass their establishment, workforce, headquarters, financial performance (if available), product range, recent advancements, and future prospects.
- Concise tabulated profiles of significant companies involved in pulsed field ablation device development emphasize company overview and product portfolio.
- Detailed scrutiny of recent initiatives within the pulsed field ablation market includes partnership analyses, funding and investment trends, patent analyses, and global event attendance by industry players.
- A detailed examination of developers in the cardiac mapping and navigation device sector focuses on establishment years, company sizes, and potential partnerships with pulsed field ablation device developers.
- An exhaustive analysis identifies and dissects factors influencing the growth of the pulsed field ablation market, encompassing drivers, restraints, emerging opportunities, and existing challenges.
- AccuPulse Medical
- Acutus Medical
- Adagio Medical
- AngioDynamics
- Arga Medtech
- AtriAN Medical
- Biosense Webster
- Boston Scientific
- CardioFocus
- CathRx
- CRC EP
- Galvanize Therapeutics
- Gradient Medical
- Hangzhou Dinova EP Technology
- Kardium
- Medtronic
- Mirai Medical
- Pulse Biosciences
- Tianjin Intelligent Health Medica
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1 Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1 Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Types of Ablation Techniques
5.3. Types of Catheter Ablation Techniques
5.3.1. Thermal Ablation Techniques
5.3.1.1. Radiofrequency Ablation
5.3.1.2. Laser Ablation
5.3.1.3. Microwave Ablation
5.3.1.4. Hydrothermal Ablation
5.3.1.5. High-Intensity Focused Ultrasound Ablation
5.3.2. Non-Thermal Ablation Techniques
5.3.2.1. Cryoablation
5.3.2.2. Mechanico-Chemical Ablation
5.3.2.3. Pulsed Field Ablation
5.4. Overview of Pulsed Field Ablation Therapy
5.4.1. Historical Evolution
5.4.2. Mechanism of Action
5.4.3. Therapeutic Applications
5.4.4. Advantages of Pulsed Field Ablation
5.5. Concluding Remarks
6. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pulsed Field Ablation Devices: Overall Market Landscape
6.2.1. Analysis by Product Components
6.2.2. Analysis by Shape of Catheter
6.2.3. Analysis by Configuration of Catheter
6.2.4. Analysis by Type of Catheter (by Irrigation)
6.2.5. Analysis by Catheter Shaft Diameter
6.2.6. Analysis by Number of Electrodes
6.2.7. Analysis by Electrical Polarity
6.2.8. Analysis by Source of Ablation
6.2.9. Analysis by Status of Development
6.2.10. Analysis by Application Area
6.2.11. Analysis by Status of Development and Location of Clinical Trial
6.2.12. Analysis by Target Therapeutic Area and Target Indication
6.2.13. Analysis by Status of Development and Target Therapeutic Area
6.2.14. Analysis by Location of Clinical Trial and Target Therapeutic Area
6.2.15 Analysis by Source of Ablation, Application Area, and Target Therapeutic Area
6.3. Pulsed Field Ablation Device Developers: Overall Market Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters (Region)
6.3.5. Analysis by Type of Developer
6.3.6. Analysis by Company Ownership
6.3.7. Analysis by Company Ownership and Location of Headquarters (Region)
6.3.8. Most Active Players: Analysis by Number of Products
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Pulsed Field Ablation Devices
7.4.1. Pulsed Field Ablation Devices Offered by Players based in North America
7.4.2. Pulsed Field Ablation Devices Offered by Players based in Europe
7.4.3. Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
7.5. Concluding Remarks
8. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. Boston Scientific
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Pulsed Field Ablation Portfolio
8.2.4. Recent Developments and Future Outlook
8.3. Medtronic
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Pulsed Field Ablation Portfolio
8.3.4. Recent Developments and Future Outlook
8.4. Galvanize Therapeutics
8.4.1. Company Overview
8.4.2. Pulsed Field Ablation Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Pulse Biosciences
8.5.1. Company Overview
8.5.2. Pulsed Field Ablation Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. AngioDynamics
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Pulsed Field Ablation Portfolio
8.6.4. Recent Developments and Future Outlook
8.7. Biosense Webster
8.7.1. Company Overview
8.7.2. Pulsed Field Ablation Portfolio
8.7.3. Recent Developments and Future Outlook
8.8. Acutus Medical
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Pulsed Field Ablation Portfolio
8.8.4. Recent Developments and Future Outlook
8.9. Kardium
8.9.1. Company Overview
8.9.2. Pulsed Field Ablation Portfolio
8.9.3. Recent Developments and Future Outlook
9. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Abbott
9.3. AccuPulse Medical
9.4. ArgŠ± Medtech
9.5. AtriAN Medical
9.6. AuriGen Medical
9.7. CathRx
9.8. ElectroPhysiology Frontiers
9.9. EnChannel Medical
9.10. Hangzhou Dinova EP Technology
9.11. Mirai Medical
9.12. Tianjin Intelligent Health Medical
10. RECENT DEVELOPMENTS AND INITIATIVES
10.1 Chapter Overview
10.2 Partnerships and Collaborations
10.2.1. Partnership Models
10.2.2. Pulsed Field Ablation: Partnerships and Collaborations
10.2.3. Analysis by Year of Partnership
10.2.4. Analysis by Type of Partnership
10.2.5. Analysis by Year and Type of Partnership
10.2.6. Analysis by Type of Product
10.2.7. Analysis by Type of Partnership and Type of Solution
10.2.8. Analysis by Therapeutic Area
10.2.9. Analysis by Type of Partnership and Therapeutic Area
10.2.10. Most Active Players: Analysis by Number of Partnerships
10.2.11. Analysis by Geography
10.2.11.1. Intercontinental and Intracontinental Agreements
10.2.11.2. Local and International Agreements
10.3. Funding and Investments
10.3.1. Funding Models
10.3.2. Pulsed Field Ablation: Funding and Investments
10.3.3. Analysis by Year of Investment
10.3.3.1. Cumulative Year-wise Trend of Funding Instances
10.3.3.2. Cumulative Year-wise Trend of Amount Invested
10.3.4. Analysis by Type of Funding
10.3.4.1. Analysis of Funding Instances
10.3.4.2. Analysis of Amount Invested
10.3.5. Analysis by Year and Type of Funding
10.3.5.1. Analysis of Funding Instances
10.3.5.2. Analysis of Amount Invested
10.3.6. Analysis of Funding Instances and Amount Invested by Therapeutic Area
10.3.7. Most Active Players: Analysis by Funding Instances
10.3.8. Most Active Players: Analysis by Amount Raised
10.3.9. Leading Investors: Analysis by Funding Instances
10.3.10. Analysis of Funding Instances and Amount Invested by Geography
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Pulsed Field Ablation: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC Symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Analysis by Patent Age
11.3.9. Leading Players: Analysis by Number of Patents
11.3.10. Leading Patent Assignees: Analysis by Number of Patents
11.4. Pulsed Field Ablation: Patent Benchmarking Analysis
11.4.1. Analysis of Top CPC Codes by Leading Industry Players
11.4.2. Analysis of Top CPC Codes by Publication Time
11.5. Pulsed Field Ablation: Patent Valuation
12. GLOBAL EVENTS ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Pulsed Field Ablation: Global Events
12.3.1. Analysis by Year of Event
12.3.2. Analysis by Type of Event
12.3.3. Analysis by Year and Type of Event
12.3.4. Analysis by Event Platform
12.3.5. Analysis by Location of Event
12.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
12.3.7. Most Active Event Organizers: Analysis by Number of Events
12.3.8. Most Active Players: Analysis by Number of Events
12.4. Global Events: Speaker Analysis
12.4.1. Most Active Speakers: Analysis by Number of Events
12.4.2. Analysis by Designation of Speakers
12.5. Concluding Remarks
13. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS
13.1. Chapter Overview
13.2. Cardiac Mapping and Navigation Device Developers
13.2.1 Analysis by Year of Establishment
13.2.2 Analysis by Company Size
13.2.3 Analysis by Location of Headquarters
13.3. Likely Partner Analysis
13.3.1. Assumptions and Key Parameters
13.3.2. Methodology
13.4. Potential Strategic Partners for Cardiac Pulsed Field Ablation Device Developers
13.4.1. Cardiac Mapping and Navigation Device Developers: Most Likely Partners
13.4.2. Cardiac Mapping and Navigation Device Developers: Likely Partners
13.4.3. Cardiac Mapping and Navigation Device Developers: Less Likely Partners
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. GLOBAL PULSED FIELD ABLATION MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation
16.6.1. Insights from Secondary Research
16.6.2. Insights from In-house Repository
16.6.3. Dynamic Dashboard
17. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Cardiovascular Disorders: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
17.4. Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Respiratory Disorders: Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
17.6. Dermatological Disorders: Historical Trends (2022) and Forecasted Estimates (2023-2035)
17.7. Data Triangulation
17.7.1. Insights from Secondary Research
17.7.2. Insights from In-house Repository
17.7.3. Dynamic Dashboard
18. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
18.4. Generators: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation
18.5.1. Insights from Secondary Research
18.5.2. Insights from In-house Repository
18.5.3. Dynamic Dashboard
19. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation
19.5.1. Insights from Secondary Research
19.5.2. Insights from In-house Repository
19.5.3. Dynamic Dashboard
20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Ablation: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.4. Ablation and Mapping: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation
20.5.1. Insights from Secondary Research
20.5.2. Insights from In-house Repository
20.5.3. Dynamic Dashboard
21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Pulsed Field: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
21.4. Pulsed Field and Radiofrequency: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.5. Pulsed Field and Cryoablation: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.6. Data Triangulation
21.6.1. Insights from Secondary Research
21.6.2. Insights from In-house Repository
21.6.3. Dynamic Dashboard
22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.1. US: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.2. Canada: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.1. China: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.2. Japan: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.6. Data Triangulation
22.6.1. Insights from Secondary Research
22.6.2. Insights from In-house Repository
22.6.3. Dynamic Dashboard
23. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY
23.1. Chapter Overview
23.2. Forecast Methodology and Key Assumptions
23.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.6. Data Triangulation
23.6.1. Insights from Secondary Research
23.6.2. Insights from In-house Repository
23.6.3. Dynamic Dashboard
24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS
24.1. Chapter Overview
24.2. Forecast Methodology and Key Assumptions
24.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.5. Data Triangulation
24.5.1. Insights from Secondary Research
24.5.2. Insights from In-house Repository
24.5.3. Dynamic Dashboard
25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER
25.1. Chapter Overview
25.2. Forecast Methodology and Key Assumptions
25.3. Soft Tissue Ablative Cancers: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.4. Pancreatic Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.5. Prostate Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.6 Non-Small Cell Lung Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.7 Esophageal Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.8 Data Triangulation
25.8.1. Insights from Secondary Research
25.8.2 Insights from In-house Repository
25.8.3. Dynamic Dashboard
26. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY
26.1 Chapter Overview
26.2. Forecast Methodology and Key Assumptions
26.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.6. Data Triangulation
26.6.1. Insights from Secondary Research
26.6.2. Insights from In-house Repository
26.6.3. Dynamic Dashboard
27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS
27.1 Chapter Overview
27.2. Forecast Methodology and Key Assumptions
27.3. Catheters : Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.5. Data Triangulation
27.5.1. Insights from Secondary Research
27.5.2. Insights from In-house Repository
27.5.3. Dynamic Dashboard
28. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS
28.1. Chapter Overview
28.2. Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035)
28.3. Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035)
28.4. Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035)
28.5. AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035)
29. CONCLUDING REMARKS
30. APPENDIX 1: TABULATED DATA
31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1 Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1 Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Types of Ablation Techniques
5.3. Types of Catheter Ablation Techniques
5.3.1. Thermal Ablation Techniques
5.3.1.1. Radiofrequency Ablation
5.3.1.2. Laser Ablation
5.3.1.3. Microwave Ablation
5.3.1.4. Hydrothermal Ablation
5.3.1.5. High-Intensity Focused Ultrasound Ablation
5.3.2. Non-Thermal Ablation Techniques
5.3.2.1. Cryoablation
5.3.2.2. Mechanico-Chemical Ablation
5.3.2.3. Pulsed Field Ablation
5.4. Overview of Pulsed Field Ablation Therapy
5.4.1. Historical Evolution
5.4.2. Mechanism of Action
5.4.3. Therapeutic Applications
5.4.4. Advantages of Pulsed Field Ablation
5.5. Concluding Remarks
6. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pulsed Field Ablation Devices: Overall Market Landscape
6.2.1. Analysis by Product Components
6.2.2. Analysis by Shape of Catheter
6.2.3. Analysis by Configuration of Catheter
6.2.4. Analysis by Type of Catheter (by Irrigation)
6.2.5. Analysis by Catheter Shaft Diameter
6.2.6. Analysis by Number of Electrodes
6.2.7. Analysis by Electrical Polarity
6.2.8. Analysis by Source of Ablation
6.2.9. Analysis by Status of Development
6.2.10. Analysis by Application Area
6.2.11. Analysis by Status of Development and Location of Clinical Trial
6.2.12. Analysis by Target Therapeutic Area and Target Indication
6.2.13. Analysis by Status of Development and Target Therapeutic Area
6.2.14. Analysis by Location of Clinical Trial and Target Therapeutic Area
6.2.15 Analysis by Source of Ablation, Application Area, and Target Therapeutic Area
6.3. Pulsed Field Ablation Device Developers: Overall Market Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters (Region)
6.3.5. Analysis by Type of Developer
6.3.6. Analysis by Company Ownership
6.3.7. Analysis by Company Ownership and Location of Headquarters (Region)
6.3.8. Most Active Players: Analysis by Number of Products
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Pulsed Field Ablation Devices
7.4.1. Pulsed Field Ablation Devices Offered by Players based in North America
7.4.2. Pulsed Field Ablation Devices Offered by Players based in Europe
7.4.3. Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
7.5. Concluding Remarks
8. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. Boston Scientific
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Pulsed Field Ablation Portfolio
8.2.4. Recent Developments and Future Outlook
8.3. Medtronic
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Pulsed Field Ablation Portfolio
8.3.4. Recent Developments and Future Outlook
8.4. Galvanize Therapeutics
8.4.1. Company Overview
8.4.2. Pulsed Field Ablation Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Pulse Biosciences
8.5.1. Company Overview
8.5.2. Pulsed Field Ablation Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. AngioDynamics
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Pulsed Field Ablation Portfolio
8.6.4. Recent Developments and Future Outlook
8.7. Biosense Webster
8.7.1. Company Overview
8.7.2. Pulsed Field Ablation Portfolio
8.7.3. Recent Developments and Future Outlook
8.8. Acutus Medical
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Pulsed Field Ablation Portfolio
8.8.4. Recent Developments and Future Outlook
8.9. Kardium
8.9.1. Company Overview
8.9.2. Pulsed Field Ablation Portfolio
8.9.3. Recent Developments and Future Outlook
9. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Abbott
9.3. AccuPulse Medical
9.4. ArgŠ± Medtech
9.5. AtriAN Medical
9.6. AuriGen Medical
9.7. CathRx
9.8. ElectroPhysiology Frontiers
9.9. EnChannel Medical
9.10. Hangzhou Dinova EP Technology
9.11. Mirai Medical
9.12. Tianjin Intelligent Health Medical
10. RECENT DEVELOPMENTS AND INITIATIVES
10.1 Chapter Overview
10.2 Partnerships and Collaborations
10.2.1. Partnership Models
10.2.2. Pulsed Field Ablation: Partnerships and Collaborations
10.2.3. Analysis by Year of Partnership
10.2.4. Analysis by Type of Partnership
10.2.5. Analysis by Year and Type of Partnership
10.2.6. Analysis by Type of Product
10.2.7. Analysis by Type of Partnership and Type of Solution
10.2.8. Analysis by Therapeutic Area
10.2.9. Analysis by Type of Partnership and Therapeutic Area
10.2.10. Most Active Players: Analysis by Number of Partnerships
10.2.11. Analysis by Geography
10.2.11.1. Intercontinental and Intracontinental Agreements
10.2.11.2. Local and International Agreements
10.3. Funding and Investments
10.3.1. Funding Models
10.3.2. Pulsed Field Ablation: Funding and Investments
10.3.3. Analysis by Year of Investment
10.3.3.1. Cumulative Year-wise Trend of Funding Instances
10.3.3.2. Cumulative Year-wise Trend of Amount Invested
10.3.4. Analysis by Type of Funding
10.3.4.1. Analysis of Funding Instances
10.3.4.2. Analysis of Amount Invested
10.3.5. Analysis by Year and Type of Funding
10.3.5.1. Analysis of Funding Instances
10.3.5.2. Analysis of Amount Invested
10.3.6. Analysis of Funding Instances and Amount Invested by Therapeutic Area
10.3.7. Most Active Players: Analysis by Funding Instances
10.3.8. Most Active Players: Analysis by Amount Raised
10.3.9. Leading Investors: Analysis by Funding Instances
10.3.10. Analysis of Funding Instances and Amount Invested by Geography
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Pulsed Field Ablation: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC Symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Analysis by Patent Age
11.3.9. Leading Players: Analysis by Number of Patents
11.3.10. Leading Patent Assignees: Analysis by Number of Patents
11.4. Pulsed Field Ablation: Patent Benchmarking Analysis
11.4.1. Analysis of Top CPC Codes by Leading Industry Players
11.4.2. Analysis of Top CPC Codes by Publication Time
11.5. Pulsed Field Ablation: Patent Valuation
12. GLOBAL EVENTS ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Pulsed Field Ablation: Global Events
12.3.1. Analysis by Year of Event
12.3.2. Analysis by Type of Event
12.3.3. Analysis by Year and Type of Event
12.3.4. Analysis by Event Platform
12.3.5. Analysis by Location of Event
12.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
12.3.7. Most Active Event Organizers: Analysis by Number of Events
12.3.8. Most Active Players: Analysis by Number of Events
12.4. Global Events: Speaker Analysis
12.4.1. Most Active Speakers: Analysis by Number of Events
12.4.2. Analysis by Designation of Speakers
12.5. Concluding Remarks
13. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS
13.1. Chapter Overview
13.2. Cardiac Mapping and Navigation Device Developers
13.2.1 Analysis by Year of Establishment
13.2.2 Analysis by Company Size
13.2.3 Analysis by Location of Headquarters
13.3. Likely Partner Analysis
13.3.1. Assumptions and Key Parameters
13.3.2. Methodology
13.4. Potential Strategic Partners for Cardiac Pulsed Field Ablation Device Developers
13.4.1. Cardiac Mapping and Navigation Device Developers: Most Likely Partners
13.4.2. Cardiac Mapping and Navigation Device Developers: Likely Partners
13.4.3. Cardiac Mapping and Navigation Device Developers: Less Likely Partners
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. GLOBAL PULSED FIELD ABLATION MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation
16.6.1. Insights from Secondary Research
16.6.2. Insights from In-house Repository
16.6.3. Dynamic Dashboard
17. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Cardiovascular Disorders: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
17.4. Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Respiratory Disorders: Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
17.6. Dermatological Disorders: Historical Trends (2022) and Forecasted Estimates (2023-2035)
17.7. Data Triangulation
17.7.1. Insights from Secondary Research
17.7.2. Insights from In-house Repository
17.7.3. Dynamic Dashboard
18. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
18.4. Generators: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation
18.5.1. Insights from Secondary Research
18.5.2. Insights from In-house Repository
18.5.3. Dynamic Dashboard
19. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation
19.5.1. Insights from Secondary Research
19.5.2. Insights from In-house Repository
19.5.3. Dynamic Dashboard
20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Ablation: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.4. Ablation and Mapping: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation
20.5.1. Insights from Secondary Research
20.5.2. Insights from In-house Repository
20.5.3. Dynamic Dashboard
21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Pulsed Field: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
21.4. Pulsed Field and Radiofrequency: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.5. Pulsed Field and Cryoablation: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.6. Data Triangulation
21.6.1. Insights from Secondary Research
21.6.2. Insights from In-house Repository
21.6.3. Dynamic Dashboard
22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.1. US: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.2. Canada: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.1. China: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.2. Japan: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.6. Data Triangulation
22.6.1. Insights from Secondary Research
22.6.2. Insights from In-house Repository
22.6.3. Dynamic Dashboard
23. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY
23.1. Chapter Overview
23.2. Forecast Methodology and Key Assumptions
23.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.6. Data Triangulation
23.6.1. Insights from Secondary Research
23.6.2. Insights from In-house Repository
23.6.3. Dynamic Dashboard
24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS
24.1. Chapter Overview
24.2. Forecast Methodology and Key Assumptions
24.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.5. Data Triangulation
24.5.1. Insights from Secondary Research
24.5.2. Insights from In-house Repository
24.5.3. Dynamic Dashboard
25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER
25.1. Chapter Overview
25.2. Forecast Methodology and Key Assumptions
25.3. Soft Tissue Ablative Cancers: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.4. Pancreatic Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.5. Prostate Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.6 Non-Small Cell Lung Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.7 Esophageal Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.8 Data Triangulation
25.8.1. Insights from Secondary Research
25.8.2 Insights from In-house Repository
25.8.3. Dynamic Dashboard
26. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY
26.1 Chapter Overview
26.2. Forecast Methodology and Key Assumptions
26.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.6. Data Triangulation
26.6.1. Insights from Secondary Research
26.6.2. Insights from In-house Repository
26.6.3. Dynamic Dashboard
27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS
27.1 Chapter Overview
27.2. Forecast Methodology and Key Assumptions
27.3. Catheters : Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.5. Data Triangulation
27.5.1. Insights from Secondary Research
27.5.2. Insights from In-house Repository
27.5.3. Dynamic Dashboard
28. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS
28.1. Chapter Overview
28.2. Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035)
28.3. Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035)
28.4. Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035)
28.5. AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035)
29. CONCLUDING REMARKS
30. APPENDIX 1: TABULATED DATA
31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
